M Tanaka
- Co-authors
- I HayakawaY OsadaKenichi SatoKatsumasa SatoKazuki HoshinoYutaka MatsuuraM KashimuraNaoyuki Toki
- Topics
- Cancer therapeutics and mechanisms (7 papers)Antibiotic Resistance in Bacteria (6 papers)Antibiotics Pharmacokinetics and Efficacy (5 papers)
- Journals
- Journal of Biological ChemistryThe Journal of ImmunologyAntimicrobial Agents and Chemotherapy
- Partner nations
- JapanChinaUnited States
In The Last Decade
M Tanaka
22 papers receiving 651 citations
Peers
Comparison fields: 5 of 87
- Molecular Biology 228
- Pharmacology 200
- Epidemiology 188
- Molecular Medicine 186
- Surgery 115
Countries citing papers authored by M Tanaka
This map shows the geographic impact of M Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Tanaka more than expected).
Fields of papers citing papers by M Tanaka
This network shows the impact of papers produced by M Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Tanaka. The network helps show where M Tanaka may publish in the future.
Co-authorship network of co-authors of M Tanaka
This figure shows the co-authorship network connecting the top 25 collaborators of M Tanaka. A scholar is included among the top collaborators of M Tanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Tanaka. M Tanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 80 | |
| 2 | 11 | |
| 3 | [A mitochondrial DNA mutation in the heteroplasmic tRNA-Tyr gene associated with chronic progressive external ophthalmoplegia--clinical and molecular biological study]. | 4 |
| 4 | 17 | |
| 5 | 65 | |
| 6 | Mitochondrial DNA mutations associated with the 11778 mutation in Leber's disease. | 6 |
| 7 | 28 | |
| 8 | The effect of DU-6859a, a new potent fluoroquinolone, on fecal microflora in human volunteers. | 7 |
| 9 | 50 | |
| 10 | 64 | |
| 11 | 96 | |
| 12 | 15 | |
| 13 | 108 | |
| 14 | 39 | |
| 15 | 41 | |
| 16 | Effect of Cyclosporin A on rat thymus: time course analysis by immunoperoxidase technique and flow cytofluorometry. | 17 |
| 17 | 0 | |
| 18 | Regulation of IgE receptor expression on human peripheral blood lymphocytes by lymphocytosis promoting factor (LPF), lectins and dexamethasone. | 9 |
| 19 | [Immunological study of Bacteroides melaninogenicus]. | 1 |
| 20 | Development of cervical cancer in surgical cases; surgical pathology of cervical cancer. | 1 |
About M Tanaka
M Tanaka is a scholar working on Molecular Medicine, Toxicology and Applied Microbiology and Biotechnology, having authored 23 papers that have together received 689 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (7 papers), Antibiotic Resistance in Bacteria (6 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). The work is most often cited by research in Molecular Medicine (186 citations), Pharmacology (200 citations) and Obstetrics and Gynecology (66 citations). M Tanaka has collaborated with scholars based in Japan, China and United States. Frequent co-authors include I Hayakawa, Y Osada, Kenichi Sato, Katsumasa Sato, Kazuki Hoshino, Yutaka Matsuura, M Kashimura, Naoyuki Toki, Toshinori Kawagoe and Yoshikuni Onodera. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Immunology and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.